C
Osteoprotegerin
Novel & Emerging BiomarkersLab test / biomarkerriskpartially modifiable
9
evidence score
Also known as: Osteoprotegerin (OPG)
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 6meta-analyses: 0trials: 3genetic: 0MR bonus:
References (3)
0 meta-analyses / systematic reviews- Osteoporosis and cardiovascular disease: a review. — Molecular biology reports 2022 · PMID 36449152
- Osteoprotegerin and Ischemic Stroke Prognosis: A Prospective Multicenter Study and Mendelian Randomization Analysis. — Stroke 2022 · PMID 36511149
- Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. — Circulation 2004 · PMID 15117849
Clinical trials (1)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT07349277 | Evaluation of sFlt-1/PlGF Ratio, Osteoprotegerin (OPG) and Soluble Endoglin (sEng) as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia | RECRUITING | OBSERVATIONAL |
Genetic associations (0)
None linked.